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We propose A step-by-step roadmap to integrate genetics in the Electronic Patient Record in Family Medicine and
clinical research. This could make urgent operationalization of readily available genetic knowledge feasible in clinical
research and consequently improved medical care.
Improving genomic literacy by training and education is needed first. The second step is the improvement of the
possibilities to register the family history in such a way that queries can identify patients at risk. Adding codes to
the ICPC chapters “A21 Personal/family history of malignancy” and “A99 Disease carrier not described further” is
proposed. Multidisciplinary guidelines for referral must be unambiguous. Electronical patient records need
possibilities to add (new) family history information, including links between individuals who are family members.
Automatic alerts should help general practitioners to recognize patients at risk who satisfy referral criteria. We
present a familial breast cancer case with a BRCA1 mutation as an example.
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Clinical researchBackground
Public health benefits of advancements in understanding
the human genome are still to be realized for common
chronic diseases such as cardiovascular disease, diabetes
mellitus, and cancer [1]. International attempts to inte-
grate and operationalize such knowledge into clinical
practice are in the early stages, and as a result, many
questions surround the current state of this translation
[1-3]. Most physicians lack genetic knowledge and skills
that might be relevant for decision support in daily prac-
tice [4]. Family history taking and family tree drawing
need to be introduced. Oversight of clinical utility of
genetic testing should be supported by eHealth facilities
to bypass unfamiliarity with facts on genetic testing.
Shortcomings in registration systems and inadequate im-
plementation of genetics in existing guidelines are
reported and result in inability to register genetic infor-Correspondence: e.houwink@vumc.nl
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in any medium, provided the original work is pmation in Electronic Patient Records. Privacy and risk of
discrimination cause concerns when registration is
considered. Consequently, inadequacy to deliver genetic
services is reported in literature [1]. We present a
roadmap (Figure 1) to integrate actual genetic know-
ledge into the Electronic Patient Record and into clinical
research in Family medicine, which would enable urgent
operationalization of readily available knowledge feasible
in daily genetic medical care.Evidence for necessary change
The clinical relevance of integrating genetics in clinical
practice was demonstrated for several familial diseases
such as colorectal cancer and breast cancer. Dove-Edwin
et al. calculated mortality risk reduction up to 80% by
identifying and subsequently screening individuals with
an increased familial colorectal cancer (CRC) risk [5].
Cancer risk management options through genetic testing
for BRCA mutations and subsequent options for pre-
ventive surgery after testing positive can empower
women and can also reduce morbidity and mortality [6].
Currently, a large number of patients in whom screening
would be beneficial, are out of sight or being missed by
their physicians [7,8].s an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Proposed roadmap to stepwise integration of genetics in the family medicine.
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Scheuner et al. identified deficiencies in primary care
workers’ basic genetic knowledge and ability to interpret
familial patterns [1]. This is in line with our prioritised
educational topics, including knowledge of basic genetic
principles, the most common genetic disorders and family
history communication skills [9]. Taylor and Edwards stated
primary care should be encouraged to invest more time
and energy in questioning and registering family history
data [10]. However, they also stressed identified barriers
such as time constraints that should be encountered. They
identified the need to develop strategies to overcome diffi-
culties preventing general practitioners (GPs) from rou-
tinely obtaining family history information as well as
strategies to support accurate record keeping in the elec-
tronic medical record (EMR) [10].
Another identified barrier is the presence of ambigu-
ous referral guidelines to clinical genetics and other
medical specialists for patients with a possible high risk
at familial disease, such as cancer [9]. Computerised de-
cision support might be helpful in familial risk assess-
ment for common cancers (e.g. breast, ovarian and
colon cancers) and would render timely genetic risk
assessments and consequently support referrals more
consistent with guidelines. These results support theimplementation of genetics education aimed at enhan-
cing effective referral indications and options.
A roadmap for translation
In order to be able to truly turn useful genetic discover-
ies from the laboratory bench to daily clinical practice, a
roadmap is crucial to make urgent translation feasible.
First, advances in the genomic literacy of health care
providers are indispensable. Secondly, innovative and
practical ICT tools to apply these newly acquired know-
ledge and skills are needed, such as registration of family
history and registry alerts supporting this.
We propose a step-by-step roadmap (Figure 1) to ef-
fectively integrate genetics in daily family medicine to
its full potential:
1. Improve basic knowledge of genetics in clinicians and
develop skills and attitude to obtain and interpret a
family history through effective education;
For example, training on oncogenetics for GPs was
recently developed and evaluated in collaboration
with The Dutch College of Family Physicians. Also, a
website on genetics targeted to GPs was developed to
easily obtain information on, amongst other topics,
genetic diseases, referral guidelines and family history
A99 D
code)
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genetics”). Oncogenetic knowledge, skills and attitude
were effectively transmitted through an accredited
online and live interactive training and could
internationally serve as an example for other
common topics (i.e. reproductive medicine, familial
coronary heart disease and diabetes) and possibly
other medical specialties provided that they are
translated to its medical systems.
2. Add relevant International Classification of Primary
Care (ICPC) codes and other coding strategies for
simple registry of family history and develop and
support coding skills;
In order to identify and track persons and/or families
at risk for hereditary diseases adequate coding is a
starting point. We propose to add a number of codes
for simple registration of family history. This will
enable and support adequate case-finding and
decision strategies [8].
Proposal for adding codes to ICPC-2 list in case
of oncogenetics
We propose to add a number of codes in order to enable
simple but structured registry of a family history. In
ICPC-2, which is the most frequently used coding sys-
tem for GPs in Western countries, these codes should
be included in Chapter A (General and Unspecified),
under A21 “Risk factor for malignancy”. ICPC-2 was
developed by the WHO and classifies patient data and
clinical activity in the domains of General/Family Prac-
tice and primary care, taking into account the frequency
distribution of problems seen in these domains. It allows
classification of the patient’s reason for encounter (RFE),
the problems/diagnosis managed, interventions, and the
ordering of these data in an episode of care struc-
ture. ICPC-2 has a biaxial structure and consists of
17 chapters, each divided into 7 components (comp.)
dealing with symptoms and complaints (comp. 1), diag-
nostic, screening and preventive procedures (comp. 2),
medication, treatment and procedures (comp. 3), test
results (comp. 4), administrative (comp. 5), referrals and
other reasons for encounter (comp. 6) and diseases
(comp. 7). (see http://www.who.int/classifications/icd/
adaptations/icpc2/en/index.html).
Mapping is available between ICPC and ICD-10, which
was also developed by the WHO for broad application in
healthcare registries. The codes suggested below for breast
cancer should suit other coding systems such as SNOMED
as well and should also be added for other cancer types.
A21 Personal/family history of malignancy (Existing code)
A21.1 One or more 1st degree family member(s) with
breast cancerA21.2 One or more 2nd degree family member(s) with
breast cancer
A21.3 One or more family member(s) with bilateral or
multifocal breast cancer
A21.4 Breast cancer in the family in one or more menisease carrier not described further (ExistingA99.1 BRCA-1 mutation carrier
A99.2 BRCA-2 mutation carrier
A99.3 TP53 mutation carrier
A99.99 Carrier of mutation in other specified gene
3. Improve access to up-to-date and unambiguous
referral guidelines;
For example, in the Netherlands multiple referral
guidelines for hereditary cancers were developed
independently (Oncoline, Foundation for detection of
hereditary tumors (In Dutch STOET), clinical
genetics centres in University hospitals and The
Dutch College of Family physicians (NHG)). Limited
usable information however is available for General
Practitioners, i.e. only for Diagnostics of Breast
Cancer and Rectal Bleeding. The guidelines are
heterogeneous and difficult to interpret We propose
to improve this by agreeing on national multi-
disciplinary referral guidelines and provide
synchronised online access to up-to-date and easy to
interpret versions.
4. Provide service or online apps to (self ) register family
history including family relations, that can be coupled
with routine healthcare registries and the EMR used in
primary care too; The best way to re-use and expand
previously recorded family history information and to
view this history from the perspective of a different
family member is by recording parent–child
relations and diagnoses with the correct family
member. This would require functionality to be
added to the EMR. In order to overcome privacy
issues an online app or website to register family
history is recommended (for example:
myfamilyhistory.com or familyhealthware.com).
5. Pro-active genetic services integrated in clinical
practice facilitated by ICT (for example family
history registry and registry alerts);
For example, the GP or nurse practitioners should be
able to (periodically) register or consult family
history information directly into the EMR. Accurate
and up-to-date treatment and referral guidelines and
subsequent automatic alerts should pop up when
certain combinations of symptoms and familial risk
factors indicate referral to a clinical geneticist or
other medical specialist.
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breast cancer case in clinical research and family medicine:
Step 1: Patient name: Angela B., Female, age 35.
Angela lives in the city with her husband and
two daughters aged 13 and 10. She works as a
hair dresser, has been happily married for a
decade and the family just bought a new home
in the suburbs. She consults the GP on a busy
Monday morning with the following complaints:
Lump in left breast which she noticed during
the weekend. The 4 cm irregular swelling is not
painful but rather sensitive. The skin on the
swelling is a little red and dimpled. Angela has
no medical history, but since you followed the
oncogenetic training for GPs a few weeks ago
you are aware of the possible familial risks of
breast cancer and decide to take her family
history. Angela’s mother died of breast cancer
when she was only 50 years of age 10 years ago.
Her mother’s father had an unknown cancer
and died at age 55. Angela tells you, when you
further ask her for her family history, her sister
had bilateral breast cancer at age 30 and died of
ovarian cancer at age 33, two years ago. Her
two other and younger sisters seem healthy.
On father’s side of the family no one has been
diagnosed with cancer yet.Step 2: If proposed codes would be added the following
could be registered:
Two first-degree family members with breast
cancer at an early age: mother (died at age 50)
and sister (age 30, died 33, bilateral breast
cancer). A21.1 and A21.3
One first-degree family member with ovarian
cancer at an early age (sister age 30, died
age 33).Step 3: You are alarmed by the family history and the
medical complaints of Angela. After checking
the referral guidelines for cancer online, you talk
with Angela about referral to the closest
hospital as soon as possible for further
diagnostics and possibly necessary surgical
treatment. You also inform her of the chance
that she might be a carrier of a DNA mutation
which could be further analysed by a clinical
geneticist. You promise to call the clinical
geneticist and discuss the problem. The clinical
geneticist agrees Angela needs further genetic
DNA testing based on this positive family
history and will invite her this week to quickly
start DNA testing, which may inform further
treatment. You call Angela afterwards and she is
grateful for taking her case so seriously.Step 4: Angela is alarmed by the fact that her positive
family history for breast and ovary cancer could
mean an added risk to her and her daughters to
develop breast or ovarian cancer and decides to
use the online tool to easily register her family
history together with her family members
during the upcoming family reunion. Although
it was a little awkward at first to ask her family
members for their medical history, they agreed
to do so anonymously online and repeat this
every 5 years. Angela shows her family tree
online to her GP who registers relevant
information in his EPD and uses this
information to build a pdf with only initials and
years of birth of family members and adds this
to her record. Not only is she now able to take
her family history to her GP, the other family
members who used the online tool are also able
to do so. The whole family is enabled to
operationalize their family history through a
snowball effect.
Step 5: Five years later Angela’s daughter Stephany,
then aged 18, visits the GP with gynaecological
problems. She feels a painful swelling. She
started to study law in a different city and her
new GP uploaded her medical and family
history into his EPD. The EPD has alarmed
Stephany’s new GP with a pop-up that Stephany
is carrier of a BRCA2 mutation since the clinical
geneticist not only diagnosed Angela with a
mutation, but unfortunately also her two
daughters. Angela’s daughter is frequently
checked with a physical and MRI by a surgeon
familiar with familial breast- and ovarian cancer
who follows the national guidelines for familial
cancer. Now that she has these complaints you
decide to call the surgeon and after careful
deliberation you refer her the same day to the
clinic for further diagnostics. Fortunately, no
abnormalities are found through the
gynaecological and vaginal ultrasound
examination.
Extending translational genetic competences
We offered our conceptual framework for stepwise inte-
gration of genetics into family medicine and clinical re-
search by adding codes to the ICPC-2 list and took
oncogenetics as an example. Of course this list could be
further improved by adding codes in case of other diseases
commonly seen in family medicine such as diabetes, car-
diovascular diseases and monogenic subtypes (Maturity
Onset Diabetes of the Young (MODY), BRCA 1/2, familial
hypercholesterolemia (FH) and long QT syndrome) in par-
ticular, are expected to come increasingly to the forefront
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is our guiding principle to improve our translational
efforts and ultimately improve (genetic) medical care. En-
gaging colleagues in health education, clinical and bio-
medical research and medicine in collaborations will
enhance our collective ability to move research from the
“data generated from research projects” phase to the
“changes in practice and policy” phase, which will then
bring us full circle to finally translate genetics in to pri-
mary care. As advances both in genetic discoveries and
health education research evolve, it will generate interdis-
ciplinary collaborative endeavors within the broader scope
of public health and medicine. Impact of these advances
will only become manifest in better decision-making, bet-
ter advocacy, better health policy and finally improved
health if GPs could play a key role in translating poten-
tially life-saving advancements in genetic technologies to
patient care. If GPs are to make an effective contribution
in this area, not only their competencies need to be
upgraded by offering suitable and effective genetics
training, but performance in real practice needs to be
facilitated as well by operationalizing integration of genet-
ics in Electronic Patient Records.Endnote
The manuscript contains original material which is
not under review elsewhere. The study on which the re-
search is based has been submitted to appropriate eth-
ical review. We have not submitted this report to any
other journal.
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